Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

Endocrine therapies such as tamoxifen and aromatase inhibitors are the standard treatment options for estrogen receptor-positive breast cancer patients. However, resistance to these agents has become a major clinical obstacle. Potential mechanisms of resistance to endocrine therapies have been ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Erin L, Lewis-Wambi, Joan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362832/
https://www.ncbi.nlm.nih.gov/pubmed/25849966
http://dx.doi.org/10.1186/s13058-015-0542-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362832/
https://www.ncbi.nlm.nih.gov/pubmed/25849966
http://dx.doi.org/10.1186/s13058-015-0542-y

Ejemplares similares